Advertisement

The Latest

A spine biologics company's $100 million investment deal and six more key updates in regenerative medicine in the last two months:

A growing number of patients are using online platforms such as Facebook, LinkedIn and Youtube to seek out healthcare providers, which presents a key opportunity for surgeons to expand their patient base. 

Houston-based FibroBiologics, a regenerative medicine company developing treatments for chronic disease using fibroblast cells, signed an agreement with a private investment group that will provide the company with up to $100 million over the next three years.

Advertisement